Research On Financial Risk Evaluation And Control Of A Pharmaceutical Company

In recent years,with the rapid development of China's economy,the market competition has become increasingly fierce,and the financial risks faced by enterprises in the process of development have become more and more complex.As a combination of traditional industry and modern industry,pharmaceutical industry is an important part of our national economy.With the improvement of national health awareness,people pay more and more attention to the prevention and treatment of diseases.The demand for medical products has further promoted the rapid development of the pharmaceutical industry.At the same time,because the pharmaceutical industry has the characteristics of high investment,high return and high risk,pharmaceutical enterprises should always pay attention to the financial risks faced by the company,and analyze and control them.A pharmaceutical company is a large-scale old pharmaceutical company in China.Taking a pharmaceutical company as an example,this paper establishes a perfect financial risk evaluation system by using entropy method and efficiency coefficient method.Through the evaluation of a pharmaceutical company's financial risk situation,it finds out the existing problems of the company and puts forward relevant suggestions.The research of this paper is helpful for a pharmaceutical company to enhance its ability of controlling financial risk,and it can be used for reference for the construction of financial risk evaluation system in pharmaceutical industry.Firstly,this thesis introduces the theory of financial risk,financial risk evaluation and financial risk control.Secondly,it introduces the basic situation of a pharmaceutical company,and analyzes the financing risk,investment risk,operation risk and cash flow risk respectively,and obtains the possibility of financial risk in a pharmaceutical company.It is found that the capital structure of the company is not reasonable,the financing method is single,and the R & D investment is less.It is necessary for a pharmaceutical company to strengthen the control of financial risk.Thirdly,combining the situation of a pharmaceutical company and the characteristics of the pharmaceutical industry,the paper constructs a financial risk evaluation system suitable for a pharmaceutical company from four aspects of financing risk,investment risk,operation risk and cash flow risk,selects the financial indicators of the company from 2014 to 2018,uses entropy method and correlation analysis to determine the weight of financial risk evaluation indicators,and communicates with The specific score of the evaluation index is calculated by the method of efficiency coefficient,and then the financial risk evaluation results of a pharmaceutical company are comprehensively analyzed.A pharmaceutical company's 2014-2018 financial risk comprehensive scores are 32.77,31.11,12.88,40.23 and 54.33 respectively,and the financial risk assessment grades are lower(d),lower(d),worse(E),medium(c)and medium(c),respectively.Finally,combined with the problems found in the company's financial risk assessment,the paper proposes to strengthen a from four aspects: financing risk,investment risk,operation risk and cash flow risk Countermeasures and suggestions for financial risk control of pharmaceutical companies include: expanding diversified financing channels,optimizing capital structure;accelerating industrial restructuring and adjustment,increasing R & D investment of enterprises,improving product competitiveness,doing a good job in feasibility analysis of investment projects;strengthening inventory and accounts receivable management;establishing cash flow risk early warning system and strengthening capital use control and other measures.